Filing Details

Accession Number:
0000899243-20-015063
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-03 16:17:17
Reporting Period:
2020-06-01
Accepted Time:
2020-06-03 16:17:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680581 Fulcrum Therapeutics Inc. FULC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577034 J Robert Gould C/O Fulcrum Therapeutics, Inc.
26 Landsdowne Street
Cambridge MA 02139
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-01 5 $20.00 549,031 No 4 S Direct
Common Stock Disposition 2020-06-02 2,797 $20.00 546,234 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019.